Lgr5 was also identified as a marker of poor prognosis in colon, ovary and liver cancers[14,15], and was considered to be involved in tumorigenesis in Barrett’s esophagus and esophageal adenocarcinoma[16]. Here, LGR5 is linked to esophageal adenocarcinoma.